RLYB RSI Chart
Last 7 days
-3.3%
Last 30 days
0.6%
Last 90 days
-11.5%
Trailing 12 Months
-70.2%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 5.8M | 0 | 0 | 0 |
2023 | 3.4M | 0 | 4.7M | 5.6M |
2022 | 134.0K | 391.0K | 904.0K | 2.0M |
2021 | 141.8K | 112.5K | 83.3K | 54.0K |
2020 | 0 | 0 | 0 | 171.0K |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 14, 2023 | lieber jonathan i | bought | 26,050 | 5.21 | 5,000 | see remarks |
Mar 07, 2023 | 5am partners v, llc | sold | -820,000 | 8.2 | -100,000 | - |
Mar 07, 2023 | parmar kush | sold | -820,000 | 8.2 | -100,000 | - |
Jun 03, 2022 | 5am opportunities i, l.p. | sold | -629,112 | 12.5 | -50,329 | - |
Jun 03, 2022 | 5am opportunities i, l.p. | sold | -1,245,890 | 12.5 | -99,671 | - |
Jun 03, 2022 | parmar kush | sold | -629,112 | 12.5 | -50,329 | - |
Jun 03, 2022 | parmar kush | sold | -1,245,890 | 12.5 | -99,671 | - |
May 23, 2022 | 5am opportunities i, l.p. | sold | -436,189 | 13.00 | -33,553 | - |
May 23, 2022 | 5am opportunities i, l.p. | sold | -863,811 | 13.00 | -66,447 | - |
May 23, 2022 | parmar kush | sold | -436,189 | 13.00 | -33,553 | - |
Which funds bought or sold RLYB recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 16, 2024 | JANE STREET GROUP, LLC | sold off | -100 | -59,078 | - | -% |
May 16, 2024 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | reduced | -31.00 | -5,603 | 6,423 | -% |
May 15, 2024 | Laurion Capital Management LP | unchanged | - | -423,032 | 1,449,270 | 0.01% |
May 15, 2024 | MARSHALL WACE, LLP | added | 93.22 | 17,800 | 53,710 | -% |
May 15, 2024 | MILLENNIUM MANAGEMENT LLC | added | 453 | 279,026 | 364,041 | -% |
May 15, 2024 | HarbourVest Partners LLC | unchanged | - | -11,814 | 40,472 | 0.02% |
May 15, 2024 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | reduced | -25.14 | -129,145 | 177,970 | -% |
May 15, 2024 | VIKING GLOBAL INVESTORS LP | unchanged | - | -2,265,180 | 7,760,340 | 0.03% |
May 15, 2024 | Voya Investment Management LLC | sold off | -100 | -31,677 | - | -% |
May 15, 2024 | Royal Bank of Canada | reduced | -92.34 | -21,000 | 1,000 | -% |
Unveiling Rallybio Corporation's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Rallybio Corporation)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 50.9B | 6.8B | -8.53 | 7.44 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.9B | 2.0B | -56.9 | 9.43 | ||||
BMRN | 14.7B | 2.5B | 71.65 | 5.96 | ||||
INCY | 12.8B | 3.8B | 17.2 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.6B | 107.9M | -10.31 | 48.09 | ||||
APLS | 5.0B | 524.1M | -12.02 | 9.57 | ||||
AXSM | 3.6B | 251.0M | -12.28 | 14.5 | ||||
ARWR | 3.1B | 240.7M | -6.53 | 12.77 | ||||
ACAD | 2.4B | 813.8M | -1.4K | 3 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.8B | 996.6M | -4.58 | 1.83 | ||||
CRBP | 480.9M | 881.7K | -14.25 | 481.06 | ||||
INO | 310.9M | 4.9M | -2.49 | 63.89 | ||||
IBIO | 17.1M | 2.1M | -0.74 | 7.61 |
Rallybio Corporation News
Income Statement (Quarterly) | ||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 |
Revenue | -11.9% | 1,276,000 | 1,448,000 | 1,545,000 | 1,546,000 | 1,071,000 | 525,000 | 270,000 | 97,000 | 12,000 | 12,000 | 13,000 | 17,000 | 29,500 | 42,000 | 47,000 |
Operating Expenses | -6.3% | 19,787,000 | 21,112,000 | 19,363,000 | 18,374,000 | 17,091,000 | 18,860,000 | 17,615,000 | 14,318,000 | 12,313,000 | 9,981,000 | 10,530,000 | 12,824,000 | - | 6,710,000 | 4,662,000 |
S&GA Expenses | -100.0% | - | 5,188,000 | 6,075,000 | 7,172,000 | 6,298,000 | 6,750,000 | 7,477,000 | 6,670,000 | 6,219,000 | 5,021,000 | 3,712,000 | 3,787,000 | - | 1,580,000 | 1,570,000 |
R&D Expenses | -18.8% | 12,936,000 | 15,924,000 | 13,288,000 | 11,202,000 | 10,793,000 | 12,110,000 | 10,138,000 | 7,648,000 | 6,094,000 | 4,960,000 | 6,818,000 | 9,037,000 | - | 5,130,000 | 3,092,000 |
EBITDA Margin | 1.4% | -12.72 | -12.90 | -14.66 | -19.95 | -33.32 | -68.16 | -136 | -348 | -840 | -298 | -220 | -175 | - | - | - |
Interest Expenses | - | - | - | - | - | - | - | - | - | - | - | - | 10,000 | - | 13,000 | 12,000 |
Income Taxes | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Earnings Before Taxes | 6.5% | -18,344,000 | -19,629,000 | -17,726,000 | -16,755,000 | -15,989,000 | -18,237,000 | -17,245,000 | -14,108,000 | -12,192,000 | -9,864,000 | -10,659,000 | -12,793,000 | - | -6,629,000 | -4,558,000 |
EBT Margin | 1.4% | -12.74 | -12.93 | -14.70 | -20.00 | -33.41 | -68.34 | -136 | -349 | -842 | -299 | -221 | -175 | - | - | - |
Net Income | 6.0% | -19,029,000 | -20,242,000 | -18,374,000 | -17,318,000 | -16,203,000 | -18,370,000 | -17,583,000 | -14,498,000 | -12,415,000 | -10,196,000 | -11,127,000 | -13,275,000 | - | -7,155,000 | -4,893,000 |
Net Income Margin | 1.3% | -13.12 | -13.29 | -15.05 | -20.36 | -33.96 | -69.54 | -139 | -359 | -870 | -317 | -235 | -186 | - | - | - |
Free Cashflow | -32.7% | -15,469,000 | -11,657,000 | -16,471,000 | -18,765,000 | -15,264,000 | -14,739,000 | -13,568,000 | -13,767,000 | -10,023,000 | -11,002,000 | -12,850,000 | -11,991,000 | - | - | - |
Balance Sheet | ||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2020Q4 |
Assets | -14.1% | 99.00 | 116 | 133 | 148 | 162 | 180 | 144 | 156 | 169 | 182 | 194 | 120 | 142 |
Current Assets | -14.2% | 99.00 | 115 | 132 | 147 | 161 | 179 | 142 | 154 | 168 | 181 | 192 | 118 | 141 |
Cash Equivalents | -21.2% | 19.00 | 24.00 | 19.00 | 33.00 | 40.00 | 57.00 | 52.00 | 61.00 | 81.00 | 175 | 187 | 113 | 140 |
Net PPE | -14.2% | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 0.00 | 0.00 | 0.00 |
Liabilities | 8.1% | 10.00 | 9.00 | 10.00 | 8.00 | 7.00 | 11.00 | 12.00 | 8.00 | 6.00 | 7.00 | 7.00 | 7.00 | 6.00 |
Current Liabilities | 8.9% | 10.00 | 9.00 | 9.00 | 8.00 | 7.00 | 11.00 | 11.00 | 7.00 | 6.00 | 7.00 | 7.00 | 7.00 | 6.00 |
Shareholder's Equity | -16.0% | 89.00 | 106 | 124 | 139 | 155 | 169 | 132 | 148 | 163 | 176 | 186 | 113 | 136 |
Retained Earnings | -8.1% | -254 | -235 | -215 | -196 | -178 | -160 | -144 | -126 | -108 | -94.03 | -81.61 | -71.42 | -47.01 |
Additional Paid-In Capital | 0.6% | 343 | 341 | 339 | 336 | 333 | 330 | 277 | 274 | 272 | 270 | 268 | - | 183 |
Shares Outstanding | 0.0% | 38.00 | 38.00 | 38.00 | 38.00 | 38.00 | 38.00 | 31.00 | 30.00 | 30.00 | 32.00 | 28.00 | 23.00 | - |
Float | - | - | - | - | 134 | - | - | - | 121 | - | 108 | - | - | - |
Cashflow (Quarterly) | |||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 |
Cashflow From Operations | -32.7% | -15,457 | -11,645 | -16,471 | -13,384 | -18,765 | -15,264 | -14,735 | -13,554 | -13,731 | -9,886 | -10,872 | -12,846 | -11,929 | - | - | - |
Share Based Compensation | -18.1% | 2,088 | 2,549 | 2,634 | 2,692 | 3,045 | 2,294 | 2,504 | 2,647 | 2,054 | 1,529 | 1,055 | 539 | 522 | - | - | - |
Cashflow From Investing | -39.3% | 10,264 | 16,909 | 3,070 | 6,214 | 1,465 | -30,646 | 5,772 | -7,118 | -80,178 | -137 | -130 | -1,504 | -562 | - | - | - |
Cashflow From Financing | -100.0% | - | 72.00 | - | 210 | -139 | 51,157 | -79.00 | - | - | -1,621 | 85,251 | -663 | - | - | - | - |
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Operating expenses: | ||
Research and development | $ 12,936 | $ 11,202 |
General and administrative | 6,851 | 7,172 |
Total operating expenses | 19,787 | 18,374 |
Loss from operations | (19,787) | (18,374) |
Other income: | ||
Interest income | 1,276 | 1,546 |
Other income | 167 | 73 |
Total other income, net | 1,443 | 1,619 |
Loss before equity in losses of joint venture | (18,344) | (16,755) |
Loss on investment in joint venture | 685 | 563 |
Net loss | $ (19,029) | $ (17,318) |
Net loss per common share, basic (in dollars per share) | $ (0.47) | $ (0.43) |
Net loss per common share, diluted (in dollars per share) | $ (0.47) | $ (0.43) |
Weighted-average common shares outstanding, basic (in shares) | 40,773,615 | 40,248,893 |
Weighted-average common shares outstanding, diluted (in shares) | 40,773,615 | 40,248,893 |
Other comprehensive (loss) gain: | ||
Net unrealized (loss) gain on marketable securities | $ (86) | $ 153 |
Other comprehensive (loss) gain | (86) | 153 |
Comprehensive loss | $ (19,115) | $ (17,165) |
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 19,301 | $ 24,494 |
Marketable securities | 74,874 | 85,435 |
Prepaid expenses and other current assets | 4,370 | 4,860 |
Total current assets | 98,545 | 114,789 |
Property and equipment, net | 211 | 246 |
Operating lease right-of-use assets | 299 | 346 |
Investment in joint venture | 304 | 239 |
Total assets | 99,359 | 115,620 |
Current liabilities: | ||
Accounts payable | 470 | 976 |
Accrued expenses | 9,393 | 8,068 |
Operating lease liabilities | 223 | 219 |
Total current liabilities | 10,086 | 9,263 |
Operating lease liabilities, noncurrent | 116 | 173 |
Total liabilities | 10,202 | 9,436 |
Commitments and contingencies (Note 7) | ||
Stockholders' equity | ||
Common stock, $0.0001 par value per share; 200,000,000 shares authorized as of March 31, 2024 and December 31, 2023, respectively; and 37,811,970 and 37,829,565 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively | 4 | 4 |
Preferred stock, $0.0001 par value per share; 50,000,000 shares authorized as of March 31, 2024 and December 31, 2023, respectively; no shares issued or outstanding as of March 31, 2024 and December 31, 2023, respectively | 0 | 0 |
Additional paid-in capital | 343,498 | 341,410 |
Accumulated other comprehensive loss | (71) | 15 |
Accumulated deficit | (254,274) | (235,245) |
Total stockholders' equity | 89,157 | 106,184 |
Total liabilities and stockholders' equity | $ 99,359 | $ 115,620 |